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Orbital exenterations and squamous cell carcinoma of the 
conjunctiva at Sekuru Kaguvi Eye Unit, Zimbabwe
*R MASANGANISE, * *A MAGAVA
Abstract
Objectives: The aim of the audit was to determine the common orbital diseases necessitating orbital 
exenterations at Sekuru Kaguvi Hospital (SKH) between January and December 1999 and recommend ways 
of reducing the numbers of procedures done annually.
Design: Retrospective cross sectional study.
Setting: Department of Surgery, Parirenyatwa Hospital, University of Zimbabwe.
Subjects: 23 patients who underwent orbital exenterations at SKH over a one year period.
Main Outcome Measure: The nature of orbital tumours requiring orbital exenteration in Zimbabwe. 
Results: A total of 23 patients underwent orbital exenteration during the period under review. Of the 23 
patients, 13 (56.5%) had squamous cell carcinoma (SCCA) of the conjunctiva with orbital extensions, 69% 
of the 13 patients were females and the mean age of these patients was 37.2 years (interquartile range 28,48). 
Conclusions: People in tropical regions, where there is a high risk of squamous cell carcinoma of the 
conjunctiva in terms of increased predisposition to solar radiation, high prevalence of HIV and inadequate eye 
care services, should seek medical attention as soon as they notice a. persistent conjunctival growth. 
Conjunctival tumours should be widely excised and material sent for histology to confirm diagnosis and 
clarity of excision margins. All patients diagnosed as having SCCA of the conjunctiva should be closely 
inonitored to facilitate early detection of recurrences and institute appropriate treatment.
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Introduction
The association of squamous cell carcinomas of the 
conjunctiva and human immunodeficiency virus (HIV) is 
well documented in the literature.1'3 Early detection and 
treatment of patients with SCCA of the conjunctiva is of 
utmost importance in terms of curing the disease and 
minimising the problems associated with managing 
advanced disease. Inadequate ophthalmic services in 
Zimbabwe coupled with harsh socio-econ om ic  
circumstances contribute to late presentation of patients 
with SCCA of the conjunctiva, thus necessitating the use 
of orbital exenteration as the most appropriate management 
option.
Orbital exenteration is a surgical procedure involving 
the removal of all orbital contents including eyelids up to 
the brow leaving the bony walls. The procedure is usually 
recommended for patients with advanced orbital 
malignancies. Itfacilitates the delivery of both radiotherapy 
and chemotherapy,4 offers the patient a chance of complete 
recovery from the disease and also improves the quality'of 
life for the patient. The procedure is very rare among 
developed countries and was fairly uncommon in our 
department during the eighties. Anecdotal reports suggest 
that the trend of orbital exenterations at Sekuru Kaguvi 
Eye Unit (SKH) has changed during the last decade. 
However, the procedure is not without problems namely: 
cosmetic (Figure I) , slow healing, risk of bone necrosis 
and infection, recurrence of the disease and the complex
Figure I: Patient who had orbital exenteration.
nature of the procedure. These problems contribute to the 
resentment of orbital exenteration by ophthalmologists 
and the patients.
The apparent increase in the frequency of orbital 
exenterations done at SKH necessitated an audit to look at 
the current nature of orbital tumours requiring this surgical 
procedure in Zimbabwe.
Materials and Methods
A hospital based retrospective study was done to look at 
records of all patients who had undergone orbital 
exenteration between 1 January and 31 December 1999 at 
SKH. Histology reports on orbital exenteration specimens 
were reviewed as well. Data on the nature of orbital 
disease, age, sex and eye involvement for each patient 
were collected. HIV status for all patients diagnosed as 
having SCGA of the conjunctiva was checked with double 
ELISA test. STATA was employed for univariate analysis 
of the data.
Statistical analysis.
Data was collected and univariate analysis of all variables 
done using STATA.
Results
A total of 23 patients had orbital exenteration done during 
the period under review. Figure II compares the annual 
cumulative frequencies of exonerations done during 1997, 
1998 and 1999 at SKH respectively. It is clear that orbital 
exenterations done at SKH are on the increase.
Figure III shows a summary of the histological diagnosis 
of orbital tumours identified on exenteration specimens 
during the year 1999. Squamous cell carcinoma of the 
conjunctiva has been identified as the commonest tumour 
found in exenteration specimens at SKH during 1999. All 
13 patients with a diagnosis of SCCA of the conjunctiva 
tested positive for HIV infection.
One male patient had CA breast secondaries in the orbit 
which presented years after mastectomy for a primary 
breast carcinoma. The patient with a basal cell carcinoma 
of the orbit had oculocutaneous albinism. The five 
unreported specimens could not be traced between theatre
Figure II: Comparison of annual cumulative frequencies of 
exenterations. -■
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Figure HI: Histological types of tumours exenterated in 
1999.
Pie chart to show  histological types of 
tumours exenterated in 1999.
Key: 1 - Squamous cell carcinoma of conjunctiva; 2  -  retinoblastoma; 3 - 
basal cell carcinoma; 4 - breast CA secondaries to orbit; 5 - unreported.
and the histology laboratory although the histology 
requisition forms had been completed in theatre.
A summary of demographic data for all the 13 patients 
withSCCAof the conjunctiva operated in 1999 is contained 
in the table below.
Table I: Summary of demographic data of 1999 patients 
with SCCA of conjuctiva
A g e  in years S ex Latera lity
M e a n  ag e  3 7 .2 F e m a le s  9 R ig h t e y e  7
In terquartile  ran g e 2 8 ,4 9 . M a le s  4 Left e y e  6
There was a statistically significant difference in sex 
distribution of the 13 patients with SCCA of the conjunctiva 
who under went orbital exenteration in 1999 (male to 
ferpale ratio of 1 : 2.25 at p = 0.016).
Discussion
Our audit has shown that the number of orbital exenterations 
performed at SKH has doubled during the past year. This 
has been due to an increasing number of patients presenting 
with advanced SCCA of the conjunctiva who required 
orbital exenteration: The increase in number of patients 
suffering from SCCA of the conjunctiva is a new 
phenomenon which could be attributed to the AIDS 
pandemic. This observation has been strengthened by the 
positive HIV test recorded in all patients who had SCCA 
of the conjunctiva.
Squamous cell carcinoma of the conjunctiva is not a rare 
condition in Zimbabwe as some ophthalmologists from 
other regions suggest.5 Our audit has revealed that 56.5% 
of orbital exenteration specimens, whose primary site was 
the conjunctiva in 1999 had SCCA. In 1997 a similar 
observation had been made by Johnson et al in Saudi 
Arabia where 54.5 % of orbital tumours were SCCA of the 
conjunctiva.6 These observations between the two 
population groups (black Zimbabweans and Asians) has 
no apparent explanation other than abundance of sunshine 
enjoyed by the two nations which may cause sol ar radiation. 
It is likely that the prevalence of SCCA of the conjunctiva
among exenterated specimens in our setting is much higher 
than the figure quoted because about 20% of the specimens 
were not reported on, as explained above.
The high rate of orbital exenteration in the management 
of SCCA of the conjunctiva in Zimbabwe could be attributed 
to several factors, namely: late presentation of patients 
with conjunctival tumours, an aggressive type of tumour 
being seen in this region and a possible link with HIV 
. infection. Evidence suggesting an association of solar 
radiation and HIV infection with SCCA of the conjunctiva 
has been documented.1'2 HIV tests done on all the 13 
patients with SCCA were positive. Unfortunately CD4 
counts were not done because of socio-economic constrains. 
However, the role of human papilloma virus in the aetiology 
of the tumour remains debatable.7
It is interesting to note that our study showed a statistically 
significant preference for females over males (p = 0.016). 
This observation supports the findings made by previous 
authors.8 The reason for this sex disparity in our audit was 
not clear and the small sample size could have introduced 
some bias in the results. A  larger prospective study on 
SCCA of the conjunctiva in this region would enlighten us 
on the natural history of the disease and its outcome to 
various management regimes.
The mean age of 37.2 years (I/R 28, 49) corresponds to 
that of HIV sufferers in developing countries in general. 
This age group comprises people who are both economically 
and socially active in their communities. The high morbidity 
and mortality associated with this disease is .likely to 
increase the burden of poverty among communities where 
national social security schemes are non-existent.
Conclusions
Squamous cell carcinoma of the conjunctiva is on the 
increase and is the commonest malignancy of the orbit 
necessitating, orbital exenteration in Zimbabwe today. 
People with persistent conjunctival growths must, therefore, 
consult an ophthalmologist early to facilitate detection and 
treatment of these tumours at an early stage. An awareness 
campaign focusing on the need for people with such 
lesions to consult eye doctors should be launched through 
the media.
Close follow up of all patients reported as having had 
malignant lesions is essential to ensure early detection of 
recurrences. This can be facilitated by establishing an 
ocular oncology clinic within the eye unit to co-ordinate 
the various activities.
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